Bicocca Open Archive

Logo unimib boa
CHINELLO, CLIZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.650
AS - Asia 8.947
EU - Europa 7.743
SA - Sud America 1.259
AF - Africa 200
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 12
Totale 32.842
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.256
SG - Singapore 3.086
IT - Italia 1.980
CN - Cina 1.954
VN - Vietnam 1.427
DE - Germania 1.132
HK - Hong Kong 1.071
RU - Federazione Russa 956
BR - Brasile 940
SE - Svezia 753
IE - Irlanda 734
GB - Regno Unito 459
FR - Francia 354
IN - India 298
AT - Austria 286
CA - Canada 275
UA - Ucraina 261
FI - Finlandia 170
KR - Corea 146
BD - Bangladesh 140
ES - Italia 131
ID - Indonesia 125
NL - Olanda 115
AR - Argentina 108
PL - Polonia 103
IQ - Iraq 94
TR - Turchia 92
DK - Danimarca 88
JP - Giappone 84
ZA - Sudafrica 70
MX - Messico 68
PK - Pakistan 54
SA - Arabia Saudita 52
EC - Ecuador 51
PH - Filippine 48
BE - Belgio 47
UZ - Uzbekistan 42
MA - Marocco 39
CH - Svizzera 37
VE - Venezuela 37
CO - Colombia 35
AU - Australia 28
IR - Iran 27
CL - Cile 25
LT - Lituania 22
CZ - Repubblica Ceca 21
EG - Egitto 19
MY - Malesia 19
PE - Perù 19
RO - Romania 19
IL - Israele 18
PY - Paraguay 18
AZ - Azerbaigian 17
UY - Uruguay 16
AE - Emirati Arabi Uniti 15
JO - Giordania 15
ET - Etiopia 14
KZ - Kazakistan 14
TW - Taiwan 14
DZ - Algeria 12
KE - Kenya 12
TH - Thailandia 12
DO - Repubblica Dominicana 11
BO - Bolivia 10
EU - Europa 10
PS - Palestinian Territory 10
BG - Bulgaria 9
KG - Kirghizistan 9
NP - Nepal 9
PT - Portogallo 9
GR - Grecia 8
LB - Libano 8
LV - Lettonia 8
PA - Panama 8
HN - Honduras 7
OM - Oman 7
TN - Tunisia 7
AL - Albania 6
SY - Repubblica araba siriana 6
BH - Bahrain 5
CR - Costa Rica 5
HR - Croazia 5
MN - Mongolia 5
NO - Norvegia 5
QA - Qatar 5
BY - Bielorussia 4
JM - Giamaica 4
KH - Cambogia 4
MT - Malta 4
NG - Nigeria 4
RS - Serbia 4
SN - Senegal 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
BN - Brunei Darussalam 3
CI - Costa d'Avorio 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
LU - Lussemburgo 3
Totale 32.800
Salva come PNG Salva come JPEG
Città #
Ann Arbor 2.129
Singapore 1.812
Ashburn 1.561
San Jose 1.050
Hong Kong 1.038
Milan 801
Fairfield 774
Dublin 724
Chandler 722
Frankfurt am Main 665
Woodbridge 626
Houston 541
Wilmington 532
Ho Chi Minh City 441
New York 391
Dallas 387
Dearborn 358
Los Angeles 338
Hanoi 334
Santa Clara 330
Seattle 329
Beijing 274
Vienna 251
Cambridge 244
Jacksonville 233
Chicago 218
Hefei 191
Shanghai 185
The Dalles 181
Princeton 175
São Paulo 140
Nanjing 136
Seoul 129
Lauterbourg 111
Buffalo 109
Orem 95
Moscow 93
Council Bluffs 92
Munich 86
Helsinki 79
Jakarta 73
Da Nang 64
Lawrence 63
Warsaw 63
Altamura 62
London 62
Guangzhou 61
Fremont 59
Kent 59
Nanchang 58
Montreal 54
Tokyo 54
Toronto 54
Denver 53
Brooklyn 49
Dong Ket 48
Nuremberg 47
Chennai 46
Baghdad 43
Haiphong 43
Amsterdam 42
Brussels 42
Ottawa 41
Stockholm 41
Atlanta 40
Lachine 40
Rome 40
San Diego 40
Johannesburg 39
Montréal 38
Tashkent 38
Rio de Janeiro 34
Hải Dương 33
San Francisco 32
Shenyang 32
Turku 31
Manchester 30
Phoenix 30
Biên Hòa 29
Zhengzhou 29
Boston 28
Changsha 28
Paris 28
Lissone 27
Ninh Bình 27
Salt Lake City 27
Florence 26
Poplar 26
Andover 25
Tianjin 25
Pune 24
Zurich 24
Hebei 23
Mumbai 23
Dhaka 22
Düsseldorf 22
Ha Long 21
Jinan 20
Basingstoke 19
Belo Horizonte 19
Totale 21.225
Salva come PNG Salva come JPEG
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 579
Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier 560
Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method 547
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 539
In-Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 532
Comparative membrane proteomics: A technical advancement in the search of renal cell carcinoma biomarkers 499
Effects of Hematuria on the Proteomic Profile of Urinary Extracellular Vesicles: Technical Challenges 466
Differential protein profiling of renal cell carcinoma urinary exosomes 456
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 448
Urinary exosomes and diabetic nephropathy: a proteomic approach 440
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 438
ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine 428
The putative role of MALDI-MSI in the study of Membranous Nephropathy 416
A novel versatile precursor suitable for 18F-radiolabeling via “click chemistry” 408
ETNK1 mutations in atypical chronic myeloid leukemia induce a mutator phenotype that can be reverted with phosphoethanolamine 408
Serum biomarkers of Renal Cell Carcinoma assessed using a protein profiling approach based on ClinProt technique 405
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 397
The proteomic landscape of renal tumors 389
Biallelic PI4KA Mutations Disrupt B-Cell Metabolism and Cause B-Cell Lymphopenia and Hypogammaglobulinemia 386
Mutual Information Optimization for Mass Spectra Data Alignment 367
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 363
Primary cell cultures from human renal cortex and renal-cell carcinoma evidence a differential expression of two spliced isoforms of Annexin A3 363
Proteomics imaging and the kidney 362
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 360
A MALDI-Mass Spectrometry Imaging method applicable to different formalin-fixed paraffin-embedded human tissues 358
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 357
Urinary extracellular vesicles and salt-losing tubulopathies: A proteomic approach 356
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 355
Different expression of Fibrinopeptide A and related fragments in serum of type 1 diabetic patients with nephropathy 347
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 342
Alterations of the serum peptidome in renal cell carcinoma discriminating benign and malignant kidney tumors 342
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 342
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 341
Functional heterogeneity of lymphocytic patterns in primary melanoma dissected through single-cell multiplexing 339
Characterization of prion protein-enriched domains, isolated from rat cerebellar granule cells in culture 335
Robust conclusions in mass spectrometry analysis 333
Protein profiling of microdomains purified from renal cell carcinoma and normal kidney tissue samples 331
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 329
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 325
Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery 321
Human urine biomarkers of renal cell carcinoma evaluated by ClinProt 316
The urinary proteome and peptidome of renal cell carcinoma patients: A comparison of different techniques 310
Tumor size, stage and grade alterations of urinary peptidome in RCC 306
Proteome analysis in thyroid pathology 305
Proteomic analysis in clear cell renal cell carcinoma: identification of differentially expressed protein by 2-D DIGE 304
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 303
Urinary Signatures of Renal Cell Carcinoma Investigated by Peptidomic Approaches 302
Aberrant N-glycosylation patterns related to serum IgG subclasses in Idiopathic membranous nephropathy 301
Urinary Peptidome and Proteome Alterations Related to Tumor Progression and Invasion in RCC 298
Analysis of correlation structures in renal cell carcinoma patient data 291
A Mutual Information Approach to Data Integration for Alzheimer’s Disease Patients 283
Proteomics in thyroid cytopathology: Relevance of MALDI-imaging in distinguishing malignant from benign lesions 282
Customization of LC-MS-based proteomic workflows for biological studies in the clinical field 281
Definition of IgG Subclass-Specific Glycopatterns in Idiopathic Membranous Nephropathy: Aberrant IgG Glycoforms in Blood 281
A molecular imaging approach to individuate tumour infiltrating lymphocytes 279
An Alternative Approach in Endocrine Pathology Research: MALDI-IMS in Papillary Thyroid Carcinoma 275
Untargeted Mass Spectrometry Approach to Study SARS-CoV-2 Proteins in Human Plasma and Saliva Proteome 274
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 274
AQP1 expression analysis in human diseases: Implications for proteomic characterization 274
Downregulation of C3 and C4A/B complement factor fragments in plasma from patients with squamous cell carcinoma of the penis 274
Intraluminal proteome and peptidome of human urinary extracellular vesicles 269
Modulation of urinary peptidome in humans exposed to high altitude hypoxia 267
Imaging mass spectrometry: a new tool for kidney disease investigations 266
Non-invasively collected amniotic fluid as a source of possible biomarkers for premature rupture of membranes investigated by proteomic approach 265
Towards the standardization of mitochondrial proteomics: the Italian mt-HPP initiative 264
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 262
Detection of high molecular weight proteins by MALDI imaging mass spectrometry 258
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 257
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 255
A Support Vector Machine Classification of Thyroid Bioptic Specimens Using MALDI-MSI Data 252
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 245
Synthesis and automated fluorine-18 radiolabeling of new PSMA-617 derivatives with a CuAAC radiosynthetic approach 245
Proteomic and bioinformatic studies for the characterization of response to pemetrexed in platinum drug resistant ovarian cancer 239
Poster: Characterization of distinguishing regions for renal cell carcinoma discrimination 237
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 236
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 236
Proteomic investigation of therapy induced senescence in cancer cells by a DIA-PASEF mass spectrometry approach 232
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 231
Untargeted mass spectrometry approach to study SARS-CoV-2 proteins and characterize human plasma and saliva proteome in COVID-19 patients. 228
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 226
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 223
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 223
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 222
Total and synaptoproteomic changes underlying response/non-response to the rapid antidepressant effect of ketamine in the hippocampus of a preclinical model of depression. 219
3D gelatin-chitosan hybrid hydrogels combined with human platelet lysate highly support human mesenchymal stem cell proliferation and osteogenic differentiation 216
Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry 207
Plasma proteome investigation of COVID-19 patients with different outcomes through an untargeted label-free LC-MS/MS approach. 201
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 201
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 198
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 192
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 188
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 187
Immunoreattività e carcinoma renale 185
Plasma proteomic signatures related to COVID-19 disease severity by an untargeted nLC-ESI-MS/MS approach 181
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 180
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 178
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 176
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 175
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 175
Method for the in vitro diagnosis of thyroid diseases 168
Totale 30.687
Salva come PNG Salva come JPEG
Categoria #
all - tutte 99.112
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 99.112
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021612 0 0 0 0 0 0 0 0 0 224 154 234
2021/20221.539 145 146 134 196 79 127 54 96 60 123 149 230
2022/20232.911 299 818 282 322 148 416 38 183 191 35 94 85
2023/20242.325 68 67 106 173 249 652 481 56 144 44 53 232
2024/20255.434 222 473 345 220 481 215 318 222 558 943 587 850
2025/202612.925 1.940 753 1.169 1.689 1.665 717 2.152 552 1.055 1.233 0 0
Totale 33.715